Technical Note: Optimal sampling schedules for kidney dosimetry based on the hybrid planar/SPECT method in 177Lu-PSMA therapy

被引:13
|
作者
Rinscheid, Andreas [1 ,2 ]
Kletting, Peter [1 ,2 ]
Eiber, Matthias [3 ]
Beer, Ambros J. [1 ]
Glatting, Gerhard [1 ,2 ]
机构
[1] Ulm Univ, Dept Nucl Med, Med Radiat Phys, D-89081 Ulm, Germany
[2] Ulm Univ, Dept Nucl Med, D-89081 Ulm, Germany
[3] Tech Univ Munich, Klinikum Rechts Isar, Dept Nucl Med, D-81675 Munich, Germany
关键词
Lu-177-PSMA; dosimetry; optimal sampling schedules; radioligand therapy; I-AND-T; SOFTWARE; TUMOR; SPECT;
D O I
10.1002/mp.13846
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose Accurate and precise renal dosimetry during Lu-177-labeled prostate-specific membrane antigen (PSMA) radioligand therapy is crucial for therapy decisions. Sampling schedules for estimating the necessary time-integrated activity coefficients (TIACs) are not optimized and standardized for clinical practice. Therefore, a simulation study to determine optimal sampling schedules (OSSs) was performed on 13 virtual Lu-177-PSMA I&T therapy patients. Method A total of 880 clinically feasible sampling schedules for planar imaging (three time points) were investigated. To simulate the hybrid planar/SPECT method, an additional quantitative SPECT/CT measurement following one planar image was considered. For each sampling schedule and patient, the activity values were generated separately. Measurement noise was modeled by drawing random numbers of log-normal distributions. The used fractional standard deviations (FSD) differed depending on the imaging modality. For activity values assigned to planar imaging, systematic noise between 25% and 75% of the total noise was simulated. After fitting with a mono-exponential function, the root-mean-squared errors of the deviations of the simulated TIACs from the ground truth for 1000 replications were used to determine the OSS. The uncertainties of the TIACs and renal dose coefficients were estimated. Results For the hybrid planar/SPECT method, OSSs were determined to be (3-4, 72-76, 124-144) h post injection (p.i.) with the quantitative SPECT/CT scan shortly after the second measurement. The accuracy and precision of the determined TIACs were in the range of (-3.0 +/- 6.2)% and (-1.0 +/- 6.5)%. This precision was improved by a factor 2-3 compared to dosimetry based on planar images only. Similar results were obtained for the renal dose coefficients. The virtual patients' renal dose coefficients were (0.68 +/- 0.24) Gy/GBq indicating that a population-based method yields an uncertainty of 35%. Conclusion Dosimetry based on the hybrid planar/SPECT method with OSS outperforms dosimetry based on planar images. The high variability in dose coefficients between the virtual patients demonstrates the need for individualized dosimetry.
引用
收藏
页码:5861 / 5866
页数:6
相关论文
共 50 条
  • [41] Bone marrow dosimetry in low volume hormone mHSPC receiving Lu-177-PSMA therapy using SPECT/CT
    Grob, D.
    Prive, B. M.
    Nagarajah, J.
    Konijnenberg, M. W.
    Peters, S. M. B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S126 - S126
  • [42] Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT
    Dagmar Grob
    Bastiaan M. Privé
    Constantijn H. J. Muselaers
    Niven Mehra
    James Nagarajah
    Mark W. Konijnenberg
    Steffie M. B. Peters
    EJNMMI Physics, 11
  • [43] Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with 177Lu-PSMA I&T therapy
    Song Xue
    Andrei Gafita
    Chao Dong
    Yu Zhao
    Giles Tetteh
    Bjoern H. Menze
    Sibylle Ziegler
    Wolfgang Weber
    Ali Afshar-Oromieh
    Axel Rominger
    Matthias Eiber
    Kuangyu Shi
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 4064 - 4072
  • [44] ACTIVITY CONCENTRATION ESTIMATION IN AUTOMATED KIDNEY SEGMENTATION BASED ON CONVOLUTION NEURAL NETWORK METHOD FOR 177LU-SPECT/CT KIDNEY DOSIMETRY
    Khan, Jehangir
    Ryden, Tobias
    Van Essen, Martijn
    Svensson, Johanna
    Bernhardt, Peter
    RADIATION PROTECTION DOSIMETRY, 2021, 195 (3-4) : 164 - 171
  • [45] Impact Of Small Patient Motion During SPECT/CT Scans Onto Activity Quantification Of 177Lu-PSMA Based on A Phantom Simulation
    Resch, S.
    Shen, X.
    Reymann, M.
    Massanes, F. Basi
    Bartenstein, P.
    Platsch, G.
    Vija, A.
    Boening, G.
    Delker, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S373 - S374
  • [46] Image-Based Bone Marrow Dosimetry in Patients Undergoing [177Lu]Lu-PSMA Radioligand Therapy
    Rumiantcev, M.
    Resch, S.
    Shen, X.
    Liubchenko, G.
    Brendel, M.
    Ziegler, S.
    Boening, G.
    Sheikh, G.
    Delker, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S164 - S164
  • [47] True Single Time Point Dosimetry for [177Lu]Lu-PSMA targeted therapy - Is Haenscheid's method applicable?
    Kurth, J.
    Heuschkel, M.
    Krause, B.
    Schwarzenboeck, S. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S743 - S743
  • [48] Time-integrated activity coefficients calculated using a physiologically based pharmacokinetic model and sampling schedules for [177Lu]Lu-PSMA-617 radioligand therapy
    Orlov, C.
    Vasic, V.
    Beer, A. J.
    Glatting, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S634 - S635
  • [49] Posttherapeutic Critical Organ Dosimetry of Extensive 177Lu-PSMA Inhibitor Therapy With Metastatic Castration-Resistant Prostate Cancer One Center Results
    Ozkan, Ahu
    Ucar, Burcu
    Seymen, Huelya
    Yarar, Yasemin Yildiz
    Falay, Fikri Okan
    Demirkol, Mehmet Onur
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (04) : 288 - 291
  • [50] Multi-Cycle 177Lu-PSMA-617 Radioligand Therapy Dosimetry Results from a Pilot SPECT/CT Study
    Fitzpatrick, Kellen
    Wong, Ka Kit
    Niedbala, Jeremy
    Roseland, Molly
    Viglianti, Benjamin
    Piert, Morand
    Frey, Kirk
    Dewaraja, Yuni
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64